Carregant...
What Have Slow Progressors Taught Us About T1D—Mind the Gap!
PURPOSE OF REVIEW: Progression rate from islet autoimmunity to clinical diabetes is unpredictable. In this review, we focus on an intriguing group of slow progressors who have high-risk islet autoantibody profiles but some remain diabetes free for decades. RECENT FINDINGS: Birth cohort studies show...
Guardat en:
| Publicat a: | Curr Diab Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733826/ https://ncbi.nlm.nih.gov/pubmed/31501992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-019-1219-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|